Women with type 1 diabetes who are pregnant or planning a pregnancy should be offered a pregnancy-specific artificial pancreas device, according to new draft guidance from NICE published on 3 June 2026. The recommendation marks one of the most significant recent NHS-backed updates in diabetes care, with the aim of helping patients manage blood glucose more effectively during a period when tight control is especially important.
A new option for pregnancy care
NICE said the device should be offered to women with type 1 diabetes who are pregnant or preparing for pregnancy. The guidance describes the technology as a pregnancy-specific artificial pancreas, reflecting a growing use of automated systems designed to support glucose management in people living with diabetes. NICE published the draft guidance as part of its latest round of health technology recommendations. ([nice.org.uk](https://www.nice.org.uk/news/articles))
The announcement came alongside other recent NICE updates, including final draft guidance on first NHS treatment options for resistant ovarian cancer and draft recommendations for liver preservation machines, underscoring the pace of new clinical decisions being issued by the health body this month. ([nice.org.uk](https://www.nice.org.uk/news/articles))
Why the guidance matters for NHS patients
Pregnancy in women with type 1 diabetes requires particularly close monitoring because blood sugar levels can affect both maternal health and pregnancy outcomes. By recommending a device specifically tailored for pregnancy, NICE is pointing toward a more individualized approach to diabetes management within the NHS. The guidance was published as draft advice, which means it may still be subject to consultation before any final implementation steps. ([nice.org.uk](https://www.nice.org.uk/news/articles))
For clinicians, the recommendation adds to the broader debate about how automated diabetes technologies can reduce the burden of day-to-day management while improving consistency of care. For patients, it may offer a more practical way to maintain control during pregnancy, when frequent adjustments are often needed.
Part of a wider wave of medical updates
The same week, Nature Medicine highlighted a new brief communication on the first identified Bundibugyo virus case in Uganda, while Nature also published coverage on rising concerns around health information, lung disease and early detection. These developments point to a busy period in medical research and public health reporting, but the NICE diabetes guidance is the clearest recent UK-focused update directly relevant to Conditions & Disease. ([nature.com](https://www.nature.com/subjects/viral-infection/nm))
With pregnancy-specific technology now entering the discussion, the latest NICE recommendation could shape how NHS teams support women with type 1 diabetes in the months ahead. If adopted, it would add another tool to help reduce risk and improve care at a crucial stage of life.
